Mutations in the epigenetic factors DNMT3A, TET2, and ASXL1 are found in approximately 70% of CH cases (3, 4, 10) and drive aberrant programs of HSC self-renewal and differentiation. This evidence concerns the gene TET2 and cyclic hematopoiesis.